# GO_molecular_function_0004: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/GO_molecular_function_0004.txt)

**Task:** `GO_molecular_function`  
**Author key, unchanged:** **D** — serine-type endopeptidase inhibitor activity

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |
| after | GPT-6 Luna | supported | reasoning-supported | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MSRILFVFLAVMAIFSTSFGQQCGLNEEFKSCGSCEPTCAKPRVTICTMECKIGCQCKSGYLRNGEGTCVLPEKC

[Multiple Choices]
A. glycosyltransferase activity
B. zinc ion binding
C. glycine hydroxymethyltransferase activity
D. serine-type endopeptidase inhibitor activity
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Gene Ontology (GO) Molecular Function Prediction, which is to predict the fundamental activity of a protein at the molecular level, as defined by the Gene Ontology (GO) 'Molecular Function' branch. This describes the elemental tasks a protein performs, such as catalysis, transport, or binding to specific molecules. Based on the protein's amino acid sequence, you are to select the option that best describes its primary molecular function.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact 75-residue sequence matches the cited UniProt record. That record reports experimentally supported inhibition of serine proteases and assigns GO:0004867 with IDA evidence, supporting D.

Citations as saved: [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3), [H4](#evidence-h4).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The N-terminal hydrophobic segment and short, cysteine-rich sequence suggest a secreted peptide, making the large-enzyme choices A and C unlikely. These features do not establish serine-protease inhibition rather than another activity, including possible metal binding.


**Missing item-specific fact**

> The protein-specific finding that this peptide inhibits serine proteases, which is established by the cited experimental annotation but is not supplied in the question.


**Reason**

> Sequence architecture narrows the choices but does not uniquely establish the molecular activity. Selecting D with confidence depends on an item-specific functional fact absent from the model input.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The reviewer evidence supports D. The sequence alone leaves uncertainty, but does not establish that another listed option is also a correct molecular-function annotation.


### Important caveats

- The functional assay and annotation are reviewer-only evidence, not information provided to the evaluated model.
- The sequence match is exact; the author’s precise source snapshot is unknown.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The N-terminal hydrophobic segment and short, cysteine-rich sequence suggest a secreted peptide, making the large-enzyme choices A and C unlikely. These features do not establish serine-protease inhibition rather than another activity, including possible metal binding.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific finding that this peptide inhibits serine proteases, which is established by the cited experimental annotation but is not supplied in the question.",
    "reason": "Sequence architecture narrows the choices but does not uniquely establish the molecular activity. Selecting D with confidence depends on an item-specific functional fact absent from the model input."
  },
  "case_id": "GO_molecular_function_0004",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C6",
      "H3",
      "H4"
    ],
    "judgment": "supported",
    "reason": "The exact 75-residue sequence matches the cited UniProt record. That record reports experimentally supported inhibition of serine proteases and assigns GO:0004867 with IDA evidence, supporting D."
  },
  "important_caveats": [
    "The functional assay and annotation are reviewer-only evidence, not information provided to the evaluated model.",
    "The sequence match is exact; the author’s precise source snapshot is unknown."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The reviewer evidence supports D. The sequence alone leaves uncertainty, but does not establish that another listed option is also a correct molecular-function annotation."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "GO_molecular_function_0004",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact 75-residue sequence matches the cited UniProt record. That record reports experimentally supported inhibition of serine proteases and assigns GO:0004867 with IDA evidence, supporting D.",
    "evidence_ids": ["C5", "C6", "H3", "H4"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The N-terminal hydrophobic segment and short, cysteine-rich sequence suggest a secreted peptide, making the large-enzyme choices A and C unlikely. These features do not establish serine-protease inhibition rather than another activity, including possible metal binding.",
    "missing_item_specific_fact": "The protein-specific finding that this peptide inhibits serine proteases, which is established by the cited experimental annotation but is not supplied in the question.",
    "reason": "Sequence architecture narrows the choices but does not uniquely establish the molecular activity. Selecting D with confidence depends on an item-specific functional fact absent from the model input."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The reviewer evidence supports D. The sequence alone leaves uncertainty, but does not establish that another listed option is also a correct molecular-function annotation."
  },
  "important_caveats": [
    "The functional assay and annotation are reviewer-only evidence, not information provided to the evaluated model.",
    "The sequence match is exact; the author’s precise source snapshot is unknown."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry U5T7E4 (sequence matched exactly, 75 aa, SHA256 identical) annotates this protein as 'Venom serine protease inhibitor BiVSPI' with GO:0004867 (serine-type endopeptidase inhibitor activity) supported by IDA (Inferred by Direct Assay, ECO:0000269) from PubMed:24158004. Experimental IC50/Ki values against chymotrypsin, subtilisin A, and proteinase K are reported. The GO annotation is an IDA-level assignment, not a computational transfer.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3), [H4](#evidence-h4), [H1](#evidence-h1).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The 75-residue sequence contains a clear N-terminal hydrophobic signal peptide (MSRILFVFLAVMAIFSTSF), eight cysteines spaced in patterns consistent with multiple disulfide bonds (C-x-x-C, C-x-C motifs typical of small inhibitor folds), and no catalytic residues (no Ser-His-Asp triad, no PLP-binding lysine, no GT-A/B motifs, no canonical Cys2His2/Cys4 zinc-binding cluster). Options A (glycosyltransferase, typically >300 aa) and C (glycine hydroxymethyltransferase, a ~350-aa PLP-dependent enzyme) are eliminated by the protein's tiny size and absence of enzyme motifs. Option B (zinc ion binding) is disfavored because the cysteine spacing matches disulfide-bonded inhibitor scaffolds rather than tetrahedral zinc-coordination geometries, and no histidines are present. The remaining architecture—small secreted, disulfide-stabilized, non-catalytic—is the hallmark of a small protease inhibitor, making D the best-supported choice by positive structural inference and elimination.


**Missing item-specific fact**

> None strictly required; however, confirming the specific 'serine-type' target class (as opposed to, e.g., a cysteine-protease inhibitor) relies on recognizing the particular inhibitor fold or knowing the venom context, which adds predictive difficulty but does not introduce an unanswerable lookup gap among the four given options.


**Reason**

> General knowledge of protein size ranges, signal peptides, disulfide-bond motifs, catalytic-site requirements, and zinc-coordination geometry provides concrete grounds to eliminate A, C, and B, and to positively infer a small secreted inhibitor fold consistent with D.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options A and C describe large enzymes incompatible with a 75-aa protein. Option B lacks a convincing zinc-coordination motif. D is the only option consistent with the observed architecture. No other option is defensible.


### Important caveats

- The GO annotation is IDA (direct assay) from a single 2014 study; the protein also exhibits antimicrobial activity against bacteria and fungi, but the GO Molecular Function term assigned is specifically the protease-inhibitor activity.
- The reviewer-only UniProt accession and metadata were not available to the evaluated model; reasoning must proceed from the raw sequence and general biology.
- The protein is a precursor (75 aa includes the signal peptide); the mature inhibitor is shorter, but this does not affect the GO MF assignment.
- The 'serine-type' specificity is supported by experimental data showing activity against chymotrypsin/subtilisin/proteinase K but not trypsin/elastase; a model reasoning purely from sequence might infer 'protease inhibitor' broadly but would still select D as the closest GO term among the four choices.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The 75-residue sequence contains a clear N-terminal hydrophobic signal peptide (MSRILFVFLAVMAIFSTSF), eight cysteines spaced in patterns consistent with multiple disulfide bonds (C-x-x-C, C-x-C motifs typical of small inhibitor folds), and no catalytic residues (no Ser-His-Asp triad, no PLP-binding lysine, no GT-A/B motifs, no canonical Cys2His2/Cys4 zinc-binding cluster). Options A (glycosyltransferase, typically >300 aa) and C (glycine hydroxymethyltransferase, a ~350-aa PLP-dependent enzyme) are eliminated by the protein's tiny size and absence of enzyme motifs. Option B (zinc ion binding) is disfavored because the cysteine spacing matches disulfide-bonded inhibitor scaffolds rather than tetrahedral zinc-coordination geometries, and no histidines are present. The remaining architecture—small secreted, disulfide-stabilized, non-catalytic—is the hallmark of a small protease inhibitor, making D the best-supported choice by positive structural inference and elimination.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "None strictly required; however, confirming the specific 'serine-type' target class (as opposed to, e.g., a cysteine-protease inhibitor) relies on recognizing the particular inhibitor fold or knowing the venom context, which adds predictive difficulty but does not introduce an unanswerable lookup gap among the four given options.",
    "reason": "General knowledge of protein size ranges, signal peptides, disulfide-bond motifs, catalytic-site requirements, and zinc-coordination geometry provides concrete grounds to eliminate A, C, and B, and to positively infer a small secreted inhibitor fold consistent with D."
  },
  "case_id": "GO_molecular_function_0004",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "H3",
      "H4",
      "H1"
    ],
    "judgment": "supported",
    "reason": "UniProt entry U5T7E4 (sequence matched exactly, 75 aa, SHA256 identical) annotates this protein as 'Venom serine protease inhibitor BiVSPI' with GO:0004867 (serine-type endopeptidase inhibitor activity) supported by IDA (Inferred by Direct Assay, ECO:0000269) from PubMed:24158004. Experimental IC50/Ki values against chymotrypsin, subtilisin A, and proteinase K are reported. The GO annotation is an IDA-level assignment, not a computational transfer."
  },
  "important_caveats": [
    "The GO annotation is IDA (direct assay) from a single 2014 study; the protein also exhibits antimicrobial activity against bacteria and fungi, but the GO Molecular Function term assigned is specifically the protease-inhibitor activity.",
    "The reviewer-only UniProt accession and metadata were not available to the evaluated model; reasoning must proceed from the raw sequence and general biology.",
    "The protein is a precursor (75 aa includes the signal peptide); the mature inhibitor is shorter, but this does not affect the GO MF assignment.",
    "The 'serine-type' specificity is supported by experimental data showing activity against chymotrypsin/subtilisin/proteinase K but not trypsin/elastase; a model reasoning purely from sequence might infer 'protease inhibitor' broadly but would still select D as the closest GO term among the four choices."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A and C describe large enzymes incompatible with a 75-aa protein. Option B lacks a convincing zinc-coordination motif. D is the only option consistent with the observed architecture. No other option is defensible."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "GO_molecular_function_0004",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry U5T7E4 (sequence matched exactly, 75 aa, SHA256 identical) annotates this protein as 'Venom serine protease inhibitor BiVSPI' with GO:0004867 (serine-type endopeptidase inhibitor activity) supported by IDA (Inferred by Direct Assay, ECO:0000269) from PubMed:24158004. Experimental IC50/Ki values against chymotrypsin, subtilisin A, and proteinase K are reported. The GO annotation is an IDA-level assignment, not a computational transfer.",
    "evidence_ids": ["C4", "C5", "C6", "H3", "H4", "H1"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The 75-residue sequence contains a clear N-terminal hydrophobic signal peptide (MSRILFVFLAVMAIFSTSF), eight cysteines spaced in patterns consistent with multiple disulfide bonds (C-x-x-C, C-x-C motifs typical of small inhibitor folds), and no catalytic residues (no Ser-His-Asp triad, no PLP-binding lysine, no GT-A/B motifs, no canonical Cys2His2/Cys4 zinc-binding cluster). Options A (glycosyltransferase, typically >300 aa) and C (glycine hydroxymethyltransferase, a ~350-aa PLP-dependent enzyme) are eliminated by the protein's tiny size and absence of enzyme motifs. Option B (zinc ion binding) is disfavored because the cysteine spacing matches disulfide-bonded inhibitor scaffolds rather than tetrahedral zinc-coordination geometries, and no histidines are present. The remaining architecture—small secreted, disulfide-stabilized, non-catalytic—is the hallmark of a small protease inhibitor, making D the best-supported choice by positive structural inference and elimination.",
    "missing_item_specific_fact": "None strictly required; however, confirming the specific 'serine-type' target class (as opposed to, e.g., a cysteine-protease inhibitor) relies on recognizing the particular inhibitor fold or knowing the venom context, which adds predictive difficulty but does not introduce an unanswerable lookup gap among the four given options.",
    "reason": "General knowledge of protein size ranges, signal peptides, disulfide-bond motifs, catalytic-site requirements, and zinc-coordination geometry provides concrete grounds to eliminate A, C, and B, and to positively infer a small secreted inhibitor fold consistent with D."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A and C describe large enzymes incompatible with a 75-aa protein. Option B lacks a convincing zinc-coordination motif. D is the only option consistent with the observed architecture. No other option is defensible."
  },
  "important_caveats": [
    "The GO annotation is IDA (direct assay) from a single 2014 study; the protein also exhibits antimicrobial activity against bacteria and fungi, but the GO Molecular Function term assigned is specifically the protease-inhibitor activity.",
    "The reviewer-only UniProt accession and metadata were not available to the evaluated model; reasoning must proceed from the raw sequence and general biology.",
    "The protein is a precursor (75 aa includes the signal peptide); the mature inhibitor is shorter, but this does not affect the GO MF assignment.",
    "The 'serine-type' specificity is supported by experimental data showing activity against chymotrypsin/subtilisin/proteinase K but not trypsin/elastase; a model reasoning purely from sequence might infer 'protease inhibitor' broadly but would still select D as the closest GO term among the four choices."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched UniProt record reports inhibitory activity against chymotrypsin and microbial serine proteases based on experimental evidence, and annotates serine-type endopeptidase inhibitor activity. This supports D for the supplied sequence.

Citations as saved: [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3), [H4](#evidence-h4).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence is a short precursor with an N-terminal hydrophobic signal-like region followed by a cysteine-rich region, a pattern consistent with a small secreted, disulfide-stabilized peptide. Such a peptide is much more compatible with a protease inhibitor than with the large catalytic machinery implied by glycosyltransferase or glycine hydroxymethyltransferase activity. Its cysteines alone do not imply zinc binding; in this context, disulfide stabilization is a plausible alternative. Thus D is meaningfully favored, though not proven from sequence alone.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> A transferable sequence-pattern inference distinguishes D from the offered alternatives without relying on the exact protein's database record. The inference is probabilistic: the sequence does not by itself establish a particular inhibitor target or experimentally verify inhibitory activity.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Among these choices, the small secreted cysteine-rich precursor pattern supports D more plausibly than the catalytic-enzyme or zinc-binding alternatives.


### Important caveats

- The reviewer-only source evidence confirms the answer for the sequence-matched record, but that record and its annotations were not part of the original model input.
- A signal-like segment and cysteine-rich mature region support, but do not independently prove, the proposed function.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is a short precursor with an N-terminal hydrophobic signal-like region followed by a cysteine-rich region, a pattern consistent with a small secreted, disulfide-stabilized peptide. Such a peptide is much more compatible with a protease inhibitor than with the large catalytic machinery implied by glycosyltransferase or glycine hydroxymethyltransferase activity. Its cysteines alone do not imply zinc binding; in this context, disulfide stabilization is a plausible alternative. Thus D is meaningfully favored, though not proven from sequence alone.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "A transferable sequence-pattern inference distinguishes D from the offered alternatives without relying on the exact protein's database record. The inference is probabilistic: the sequence does not by itself establish a particular inhibitor target or experimentally verify inhibitory activity."
  },
  "case_id": "GO_molecular_function_0004",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C6",
      "H3",
      "H4"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record reports inhibitory activity against chymotrypsin and microbial serine proteases based on experimental evidence, and annotates serine-type endopeptidase inhibitor activity. This supports D for the supplied sequence."
  },
  "important_caveats": [
    "The reviewer-only source evidence confirms the answer for the sequence-matched record, but that record and its annotations were not part of the original model input.",
    "A signal-like segment and cysteine-rich mature region support, but do not independently prove, the proposed function."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among these choices, the small secreted cysteine-rich precursor pattern supports D more plausibly than the catalytic-enzyme or zinc-binding alternatives."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "GO_molecular_function_0004",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record reports inhibitory activity against chymotrypsin and microbial serine proteases based on experimental evidence, and annotates serine-type endopeptidase inhibitor activity. This supports D for the supplied sequence.",
    "evidence_ids": ["C5", "C6", "H3", "H4"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence is a short precursor with an N-terminal hydrophobic signal-like region followed by a cysteine-rich region, a pattern consistent with a small secreted, disulfide-stabilized peptide. Such a peptide is much more compatible with a protease inhibitor than with the large catalytic machinery implied by glycosyltransferase or glycine hydroxymethyltransferase activity. Its cysteines alone do not imply zinc binding; in this context, disulfide stabilization is a plausible alternative. Thus D is meaningfully favored, though not proven from sequence alone.",
    "missing_item_specific_fact": "",
    "reason": "A transferable sequence-pattern inference distinguishes D from the offered alternatives without relying on the exact protein's database record. The inference is probabilistic: the sequence does not by itself establish a particular inhibitor target or experimentally verify inhibitory activity."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among these choices, the small secreted cysteine-rich precursor pattern supports D more plausibly than the catalytic-enzyme or zinc-binding alternatives."
  },
  "important_caveats": [
    "The reviewer-only source evidence confirms the answer for the sequence-matched record, but that record and its annotations were not part of the original model input.",
    "A signal-like segment and cysteine-rich mature region support, but do not independently prove, the proposed function."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry U5T7E4 (Swiss-Prot, sequence matched) annotates this protein as 'Venom serine protease inhibitor BiVSPI' from Bombus ignitus, with GO:0004867 (serine-type endopeptidase inhibitor activity) supported by IDA evidence from PubMed:24158004. Functional assays confirm inhibitory activity against chymotrypsin, subtilisin A, and proteinase K. The expected answer D is directly supported by experimental evidence.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3), [H4](#evidence-h4).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence is only 75 amino acids with a hydrophobic N-terminal signal peptide followed by a highly cysteine-rich mature region (~10 Cys in ~55 residues). Transferable knowledge allows elimination of A and C: glycosyltransferases and glycine hydroxymethyltransferases are large multi-domain enzymes (typically 300-500+ residues) with specific catalytic and cofactor-binding sites; a 75-residue secreted protein cannot perform these catalytic functions. The signal peptide indicates a secreted protein, inconsistent with intracellular metabolic enzymes. The small size, secretion signal, and dense cysteine network with regular spacing are hallmarks of small disulfide-rich inhibitor domains (Kunitz, WAP, or similar) found abundantly in arthropod venoms and known to inhibit serine proteases. Zinc binding (B) requires specific Cys/His coordination geometry (e.g., Cys2His2, Cys4 clusters); the cysteine spacing here is consistent with structural disulfide bonds stabilizing a compact inhibitory fold rather than a zinc-coordinating site. Thus, family-level knowledge of small secreted cysteine-rich venom proteins and basic size/structural constraints meaningfully distinguishes D.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> A knowledgeable model can use (1) size constraints to eliminate large enzyme options A and C, (2) signal peptide + small cysteine-rich architecture to recognize a secreted small-domain protein, and (3) family knowledge of Kunitz/WAP-type serine protease inhibitors in venoms to select D over B. The cysteine spacing pattern does not match canonical zinc-binding motifs. This is a defensible probabilistic inference from transferable protein-family knowledge.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options A and C are eliminated by size constraints (75 aa is far too small for transferase or hydroxymethyltransferase enzymes). Option B is disfavored because the cysteine spacing matches structural disulfide bonds of a protease-inhibitor fold rather than a zinc-coordination motif. D is the only option consistent with a small, secreted, cysteine-rich protein with Kunitz/WAP-like architecture.


### Important caveats

- The reviewer-only evidence confirms the exact UniProt accession and experimental IDA annotation, but these were not available to the evaluated model.
- The cysteine spacing analysis is qualitative; without the exact disulfide connectivity, one cannot rule out all zinc-binding possibilities with absolute certainty, but the overall architecture strongly favors a protease-inhibitor fold.
- The protein's antimicrobial activity (binding bacteria/fungi) is noted in the source but is not among the answer choices; the primary molecular function annotated is serine-type endopeptidase inhibition.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is only 75 amino acids with a hydrophobic N-terminal signal peptide followed by a highly cysteine-rich mature region (~10 Cys in ~55 residues). Transferable knowledge allows elimination of A and C: glycosyltransferases and glycine hydroxymethyltransferases are large multi-domain enzymes (typically 300-500+ residues) with specific catalytic and cofactor-binding sites; a 75-residue secreted protein cannot perform these catalytic functions. The signal peptide indicates a secreted protein, inconsistent with intracellular metabolic enzymes. The small size, secretion signal, and dense cysteine network with regular spacing are hallmarks of small disulfide-rich inhibitor domains (Kunitz, WAP, or similar) found abundantly in arthropod venoms and known to inhibit serine proteases. Zinc binding (B) requires specific Cys/His coordination geometry (e.g., Cys2His2, Cys4 clusters); the cysteine spacing here is consistent with structural disulfide bonds stabilizing a compact inhibitory fold rather than a zinc-coordinating site. Thus, family-level knowledge of small secreted cysteine-rich venom proteins and basic size/structural constraints meaningfully distinguishes D.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "A knowledgeable model can use (1) size constraints to eliminate large enzyme options A and C, (2) signal peptide + small cysteine-rich architecture to recognize a secreted small-domain protein, and (3) family knowledge of Kunitz/WAP-type serine protease inhibitors in venoms to select D over B. The cysteine spacing pattern does not match canonical zinc-binding motifs. This is a defensible probabilistic inference from transferable protein-family knowledge."
  },
  "case_id": "GO_molecular_function_0004",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "H3",
      "H4"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry U5T7E4 (Swiss-Prot, sequence matched) annotates this protein as 'Venom serine protease inhibitor BiVSPI' from Bombus ignitus, with GO:0004867 (serine-type endopeptidase inhibitor activity) supported by IDA evidence from PubMed:24158004. Functional assays confirm inhibitory activity against chymotrypsin, subtilisin A, and proteinase K. The expected answer D is directly supported by experimental evidence."
  },
  "important_caveats": [
    "The reviewer-only evidence confirms the exact UniProt accession and experimental IDA annotation, but these were not available to the evaluated model.",
    "The cysteine spacing analysis is qualitative; without the exact disulfide connectivity, one cannot rule out all zinc-binding possibilities with absolute certainty, but the overall architecture strongly favors a protease-inhibitor fold.",
    "The protein's antimicrobial activity (binding bacteria/fungi) is noted in the source but is not among the answer choices; the primary molecular function annotated is serine-type endopeptidase inhibition."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A and C are eliminated by size constraints (75 aa is far too small for transferase or hydroxymethyltransferase enzymes). Option B is disfavored because the cysteine spacing matches structural disulfide bonds of a protease-inhibitor fold rather than a zinc-coordination motif. D is the only option consistent with a small, secreted, cysteine-rich protein with Kunitz/WAP-like architecture."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "GO_molecular_function_0004",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry U5T7E4 (Swiss-Prot, sequence matched) annotates this protein as 'Venom serine protease inhibitor BiVSPI' from Bombus ignitus, with GO:0004867 (serine-type endopeptidase inhibitor activity) supported by IDA evidence from PubMed:24158004. Functional assays confirm inhibitory activity against chymotrypsin, subtilisin A, and proteinase K. The expected answer D is directly supported by experimental evidence.",
    "evidence_ids": ["C4", "C5", "C6", "H3", "H4"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence is only 75 amino acids with a hydrophobic N-terminal signal peptide followed by a highly cysteine-rich mature region (~10 Cys in ~55 residues). Transferable knowledge allows elimination of A and C: glycosyltransferases and glycine hydroxymethyltransferases are large multi-domain enzymes (typically 300-500+ residues) with specific catalytic and cofactor-binding sites; a 75-residue secreted protein cannot perform these catalytic functions. The signal peptide indicates a secreted protein, inconsistent with intracellular metabolic enzymes. The small size, secretion signal, and dense cysteine network with regular spacing are hallmarks of small disulfide-rich inhibitor domains (Kunitz, WAP, or similar) found abundantly in arthropod venoms and known to inhibit serine proteases. Zinc binding (B) requires specific Cys/His coordination geometry (e.g., Cys2His2, Cys4 clusters); the cysteine spacing here is consistent with structural disulfide bonds stabilizing a compact inhibitory fold rather than a zinc-coordinating site. Thus, family-level knowledge of small secreted cysteine-rich venom proteins and basic size/structural constraints meaningfully distinguishes D.",
    "missing_item_specific_fact": "",
    "reason": "A knowledgeable model can use (1) size constraints to eliminate large enzyme options A and C, (2) signal peptide + small cysteine-rich architecture to recognize a secreted small-domain protein, and (3) family knowledge of Kunitz/WAP-type serine protease inhibitors in venoms to select D over B. The cysteine spacing pattern does not match canonical zinc-binding motifs. This is a defensible probabilistic inference from transferable protein-family knowledge."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A and C are eliminated by size constraints (75 aa is far too small for transferase or hydroxymethyltransferase enzymes). Option B is disfavored because the cysteine spacing matches structural disulfide bonds of a protease-inhibitor fold rather than a zinc-coordination motif. D is the only option consistent with a small, secreted, cysteine-rich protein with Kunitz/WAP-like architecture."
  },
  "important_caveats": [
    "The reviewer-only evidence confirms the exact UniProt accession and experimental IDA annotation, but these were not available to the evaluated model.",
    "The cysteine spacing analysis is qualitative; without the exact disulfide connectivity, one cannot rule out all zinc-binding possibilities with absolute certainty, but the overall architecture strongly favors a protease-inhibitor fold.",
    "The protein's antimicrobial activity (binding bacteria/fungi) is noted in the source but is not among the answer choices; the primary molecular function annotated is serine-type endopeptidase inhibition."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "U5T7E4",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "757379394f3af43718c4610b5c8e93b2db02a5de7f8f6564c801dc74a76f02a2",
  "benchmark_sequence_length": 75,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 33,
    "firstPublicDate": "2025-06-18",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2014-01-22",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "fbc5842cbc1fb8fdcf4a2ce81aee2d573a2a31b81dfaeaf9b3fede6c3e1b848c",
  "current_source_sequence_sha256": "757379394f3af43718c4610b5c8e93b2db02a5de7f8f6564c801dc74a76f02a2",
  "current_source_sequence_length": 75,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 31,
  "selected_historical_version": {
    "accession": "U5T7E4",
    "database": "Swiss-Prot",
    "entryVersion": 31,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "TILVI_BOMIG",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "d7145a1a4accaf1efa4f61bacd7f1b5022feb4fe402ba99e5f1997756e2c42eb",
  "selected_historical_source_sequence_sha256": "757379394f3af43718c4610b5c8e93b2db02a5de7f8f6564c801dc74a76f02a2",
  "selected_historical_source_sequence_length": 75,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 31,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.
- Ontology names and EXACT synonyms match options mechanically; no answer-support judgment is made.
- Only is_a and part_of edges are used in supplied graph paths; all qualifiers and obsolete/replaced_by tags remain in literal source blocks.
- The ontology is newer than the benchmark repository commit; the exact author ontology snapshot is unknown.
- No matching term or path does not establish that an option is false.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/U5T7E4.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/U5T7E4.json",
  "source_sha256": "fbc5842cbc1fb8fdcf4a2ce81aee2d573a2a31b81dfaeaf9b3fede6c3e1b848c",
  "retrieved_utc": "2026-11-02T04:34:01.726773+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"U5T7E4\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/U5T7E4.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/U5T7E4.json",
  "source_sha256": "fbc5842cbc1fb8fdcf4a2ce81aee2d573a2a31b81dfaeaf9b3fede6c3e1b848c",
  "retrieved_utc": "2026-11-02T04:34:01.726773+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":33,\"firstPublicDate\":\"2025-06-18\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2014-01-22\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/U5T7E4.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/U5T7E4.json",
  "source_sha256": "fbc5842cbc1fb8fdcf4a2ce81aee2d573a2a31b81dfaeaf9b3fede6c3e1b848c",
  "retrieved_utc": "2026-11-02T04:34:01.726773+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"commonName\":\"Fiery-tailed bumble bee\",\"lineage\":[\"Eukaryota\",\"Metazoa\",\"Ecdysozoa\",\"Arthropoda\",\"Altocrustacea\",\"Allotriocarida\",\"Hexapoda\",\"Insecta\",\"Pterygota\",\"Neoptera\",\"Eumetabola\",\"Endopterygota\",\"Hymenoptera\",\"Apocrita\",\"Aculeata\",\"Apoidea\",\"Anthophila\",\"Apidae\",\"Bombus\",\"Bombus\"],\"scientificName\":\"Bombus ignitus\",\"taxonId\":130704}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/U5T7E4.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/U5T7E4.json",
  "source_sha256": "fbc5842cbc1fb8fdcf4a2ce81aee2d573a2a31b81dfaeaf9b3fede6c3e1b848c",
  "retrieved_utc": "2026-11-02T04:34:01.726773+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"flag\":\"Precursor\",\"recommendedName\":{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"24158004\",\"source\":\"PubMed\"}],\"value\":\"Venom serine protease inhibitor BiVSPI\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/U5T7E4.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/U5T7E4.json",
  "source_sha256": "fbc5842cbc1fb8fdcf4a2ce81aee2d573a2a31b81dfaeaf9b3fede6c3e1b848c",
  "retrieved_utc": "2026-11-02T04:34:01.726773+00:00",
  "json_pointer": "/comments/0",
  "excerpt": "{\"commentType\":\"FUNCTION\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"24158004\",\"source\":\"PubMed\"}],\"value\":\"Antimicrobial venom serine protease inhibitor. Exhibits inhibitory activity against chymotrypsin (IC(50)=19.56 nM, Ki=15.24 nM) and microbial serine proteases, such as subtilisin A (IC(50)=6.57 nM, Ki=6.83 nM) and proteinase K (IC(50)=7.11 nM, Ki=7.02 nM). Has not activity against trypsin, plasmin, tPA, thrombin, factor Xa or elastase. Binds and inhibits Gram-positive bacteria (B.subtilis (MIC=29.45 uM), B.thuringiensis (MIC=91.03 uM)) and the entomopathogenic fungus B.bassiana (MIC=30.09 uM) but not to E.coli\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/U5T7E4.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/U5T7E4.json",
  "source_sha256": "fbc5842cbc1fb8fdcf4a2ce81aee2d573a2a31b81dfaeaf9b3fede6c3e1b848c",
  "retrieved_utc": "2026-11-02T04:34:01.726773+00:00",
  "json_pointer": "/uniProtKBCrossReferences/5",
  "excerpt": "{\"database\":\"GO\",\"evidences\":[{\"evidenceCode\":\"ECO:0000314\",\"id\":\"24158004\",\"source\":\"PubMed\"}],\"id\":\"GO:0004867\",\"properties\":[{\"key\":\"GoTerm\",\"value\":\"F:serine-type endopeptidase inhibitor activity\"},{\"key\":\"GoEvidenceType\",\"value\":\"IDA:UniProtKB\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C7

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/U5T7E4.json)

```json
{
  "evidence_id": "C7",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/U5T7E4.json",
  "source_sha256": "fbc5842cbc1fb8fdcf4a2ce81aee2d573a2a31b81dfaeaf9b3fede6c3e1b848c",
  "retrieved_utc": "2026-11-02T04:34:01.726773+00:00",
  "json_pointer": "/references/0",
  "excerpt": "{\"citation\":{\"authors\":[\"Wan H.\",\"Kim B.Y.\",\"Lee K.S.\",\"Yoon H.J.\",\"Lee K.Y.\",\"Jin B.R.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"24158004\"},{\"database\":\"DOI\",\"id\":\"10.1016/j.cbpb.2013.10.002\"}],\"citationType\":\"journal article\",\"firstPage\":\"59\",\"id\":\"24158004\",\"journal\":\"Comp. Biochem. Physiol.\",\"lastPage\":\"64\",\"publicationDate\":\"2014\",\"title\":\"A bumblebee (Bombus ignitus) venom serine protease inhibitor that acts as a microbial serine protease inhibitor.\",\"volume\":\"167\"},\"evidences\":[{\"evidenceCode\":\"ECO:0000312\",\"id\":\"AGY95442.1\",\"source\":\"EMBL\"}],\"referenceComments\":[{\"type\":\"TISSUE\",\"value\":\"Venom\"},{\"type\":\"TISSUE\",\"value\":\"Venom gland\"}],\"referenceNumber\":1,\"referencePositions\":[\"NUCLEOTIDE SEQUENCE [MRNA]\",\"FUNCTION\",\"TISSUE SPECIFICITY\",\"SUBCELLULAR LOCATION\",\"RECOMBINANT EXPRESSION\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/U5T7E4?format=txt&versions=31)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/U5T7E4?format=txt&versions=31",
  "source_sha256": "d7145a1a4accaf1efa4f61bacd7f1b5022feb4fe402ba99e5f1997756e2c42eb",
  "retrieved_utc": "2026-11-02T04:34:04.526434+00:00",
  "source_locator": "lines 1-12",
  "excerpt": "ID   TILVI_BOMIG             Reviewed;          75 AA.\nAC   U5T7E4;\nDT   18-JUN-2025, integrated into UniProtKB/Swiss-Prot.\nDT   22-JAN-2014, sequence version 1.\nDT   28-JAN-2026, entry version 31.\nDE   RecName: Full=Venom serine protease inhibitor BiVSPI {ECO:0000303|PubMed:24158004};\nDE   Flags: Precursor;\nOS   Bombus ignitus (Bumblebee).\nOC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota;\nOC   Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Apoidea;\nOC   Anthophila; Apidae; Bombus; Bombus.\nOX   NCBI_TaxID=130704;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 31,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/U5T7E4?format=txt&versions=31)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/U5T7E4?format=txt&versions=31",
  "source_sha256": "d7145a1a4accaf1efa4f61bacd7f1b5022feb4fe402ba99e5f1997756e2c42eb",
  "retrieved_utc": "2026-11-02T04:34:04.526434+00:00",
  "source_locator": "lines 13-21",
  "excerpt": "RN   [1] {ECO:0000312|EMBL:AGY95442.1}\nRP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, SUBCELLULAR\nRP   LOCATION, AND RECOMBINANT EXPRESSION.\nRC   TISSUE=Venom, and Venom gland;\nRX   PubMed=24158004; DOI=10.1016/j.cbpb.2013.10.002;\nRA   Wan H., Kim B.Y., Lee K.S., Yoon H.J., Lee K.Y., Jin B.R.;\nRT   \"A bumblebee (Bombus ignitus) venom serine protease inhibitor that acts as\nRT   a microbial serine protease inhibitor.\";\nRL   Comp. Biochem. Physiol. 167:59-64(2014).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 31,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/U5T7E4?format=txt&versions=31)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/U5T7E4?format=txt&versions=31",
  "source_sha256": "d7145a1a4accaf1efa4f61bacd7f1b5022feb4fe402ba99e5f1997756e2c42eb",
  "retrieved_utc": "2026-11-02T04:34:04.526434+00:00",
  "source_locator": "lines 22-30",
  "excerpt": "CC   -!- FUNCTION: Antimicrobial venom serine protease inhibitor. Exhibits\nCC       inhibitory activity against chymotrypsin (IC(50)=19.56 nM, Ki=15.24 nM)\nCC       and microbial serine proteases, such as subtilisin A (IC(50)=6.57 nM,\nCC       Ki=6.83 nM) and proteinase K (IC(50)=7.11 nM, Ki=7.02 nM). Has not\nCC       activity against trypsin, plasmin, tPA, thrombin, factor Xa or\nCC       elastase. Binds and inhibits Gram-positive bacteria (B.subtilis\nCC       (MIC=29.45 uM), B.thuringiensis (MIC=91.03 uM)) and the\nCC       entomopathogenic fungus B.bassiana (MIC=30.09 uM) but not to E.coli.\nCC       {ECO:0000269|PubMed:24158004}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 31,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/U5T7E4?format=txt&versions=31)

```json
{
  "evidence_id": "H4",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/U5T7E4?format=txt&versions=31",
  "source_sha256": "d7145a1a4accaf1efa4f61bacd7f1b5022feb4fe402ba99e5f1997756e2c42eb",
  "retrieved_utc": "2026-11-02T04:34:04.526434+00:00",
  "source_locator": "lines 46-46",
  "excerpt": "DR   GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IDA:UniProtKB.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 31,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence GO1

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO1",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 40906-40925",
  "excerpt": "[Term]\nid: GO:0004372\nname: glycine hydroxymethyltransferase activity\nnamespace: molecular_function\ndef: \"Catalysis of the reaction: (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate + glycine + H2O = (6S)-5,6,7,8-tetrahydrofolate + L-serine.\" [RHEA:15481]\nsynonym: \"5,10-methylenetetrahydrofolate:glycine hydroxymethyltransferase activity\" RELATED [EC:2.1.2.1]\nsynonym: \"allothreonine aldolase activity\" RELATED [EC:2.1.2.1]\nsynonym: \"L-serine hydroxymethyltransferase activity\" RELATED [EC:2.1.2.1]\nsynonym: \"serine aldolase activity\" RELATED [EC:2.1.2.1]\nsynonym: \"serine hydroxymethylase activity\" RELATED [EC:2.1.2.1]\nsynonym: \"serine hydroxymethyltransferase activity\" RELATED [EC:2.1.2.1]\nsynonym: \"serine transhydroxymethylase activity\" RELATED [EC:2.1.2.1]\nxref: MetaCyc:GLYOHMETRANS-RXN\nxref: Reactome:R-HSA-5694137 \"PXLP-K280-SHMT2 tetramer transfers CH2OH group to Gly to form L-Ser\"\nxref: RHEA:15481\nis_a: GO:0016742 ! hydroxymethyl-, formyl- and related transferase activity\nproperty_value: skos:broadMatch EC:2.1.2.1\nproperty_value: skos:exactMatch MetaCyc:GLYOHMETRANS-RXN\nproperty_value: skos:exactMatch RHEA:15481\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:0004372"
}
```

### Evidence GO2

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO2",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 51576-51590",
  "excerpt": "[Term]\nid: GO:0004867\nname: serine-type endopeptidase inhibitor activity\nnamespace: molecular_function\ndef: \"Binds to and stops, prevents or reduces the activity of a serine-type endopeptidase.\" [GOC:ai]\nsynonym: \"serine protease inhibitor activity\" NARROW []\nsynonym: \"serine proteinase inhibitor activity\" NARROW []\nsynonym: \"serpin activity\" NARROW []\nxref: Reactome:R-HSA-158795 \"fibrin multimer, crosslinked:tissue plasminogen activator (one-chain) + plasminogen activator inhibitor 1 -> fibrin multimer, crosslinked:tissue plasminogen activator (one-chain):plasminogen activator inhibitor 1\"\nxref: Reactome:R-HSA-158800 \"fibrin multimer, crosslinked:tissue plasminogen activator (two-chain) + plasminogen activator inhibitor 1 -> fibrin multimer, crosslinked:tissue plasminogen activator (two-chain):plasminogen activator inhibitor 1\"\nxref: Reactome:R-HSA-158893 \"alpha-2-antiplasmin + plasmin -> alpha-2-antiplasmin:plasmin\"\nxref: Reactome:R-HSA-159001 \"urokinase plasminogen activator (two-chain):uPAR + plasminogen activator inhibitor 2 (PAI-2) -> PAI-2:urokinase plasminogen activator (two-chain):uPAR\"\nxref: Reactome:R-HSA-159005 \"urokinase plasminogen activator (two-chain):uPAR + plasminogen activator inhibitor 1 (PAI-1) -> PAI-1:urokinase plasminogen activator (two-chain):uPAR\"\nis_a: GO:0004866 ! endopeptidase inhibitor activity\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:0004867"
}
```

### Evidence GO3

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO3",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 81431-81439",
  "excerpt": "[Term]\nid: GO:0008270\nname: zinc ion binding\nnamespace: molecular_function\ndef: \"Binding to a zinc ion (Zn).\" [GOC:ai]\nsynonym: \"zinc binding\" EXACT []\nsynonym: \"Zn binding\" EXACT []\nis_a: GO:0046914 ! transition metal ion binding\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:0008270"
}
```

### Evidence GO4

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO4",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 129828-129846",
  "excerpt": "[Term]\nid: GO:0016757\nname: glycosyltransferase activity\nnamespace: molecular_function\nalt_id: GO:0016932\ndef: \"Catalysis of the transfer of a glycosyl group from one compound (donor) to another (acceptor).\" [GOC:jl, ISBN:0198506732]\nsubset: goslim_chembl\nsubset: goslim_drosophila\nsubset: goslim_yeast\nsynonym: \"transferase activity, transferring glycosyl groups\" EXACT []\nsynonym: \"transferase activity, transferring other glycosyl groups\" NARROW []\nsynonym: \"transglycosidase activity\" EXACT []\nsynonym: \"transglycosylase activity\" EXACT []\nxref: EC:2.4.-.-\nxref: Reactome:R-HSA-5173005 \"B3GALTL transfers glucose to O-fucosyl-proteins\"\nxref: Reactome:R-HSA-6785565 \"Defective B3GALTL does not transfer glucose to O-fucosyl-proteins\"\nis_a: GO:0016740 ! transferase activity\nproperty_value: skos:exactMatch EC:2.4.-.-\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:0016757"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/GO_molecular_function.json), zero-based source row 4. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
